Literature DB >> 23055190

Bone marrow-derived cells contribute to NDEA-induced lung squamous cell carcinoma.

Dan Luo1, Dengqun Liu, Xiangdong Zhou, Shiming Yang, Chunlan Tang, Guoxiang Liu.   

Abstract

Bone marrow-derived stem cells (BMDCs) have the ability to differentiate into lung epithelial cells in response to damage; however, their role in squamous cell carcinoma (SCC) formation is unknown. This study aimed to determine whether BMDC-derived lung epithelial cells could contribute to SCC formation. A model of lung SCC induced with N-nitrosodiethylamine (NDEA) in recipient female mice transplanted with green fluorescent protein (GFP)-positive BMDCs from male donors was established. Incorporation of BMDCs in lung tissue was determined using immunohistochemistry and immunofluorescence to detect GFP expression and fluorescence in situ hybridization to Y chromosomes. BMDC appeared at three stages of lung SCC progression: metaplasia, dysplasia, and carcinoma. There was a significantly higher proportion of GFP-positive (GFP(+)) cells within SCC than was found in metaplasia and dysplasia 16 weeks post-transplantation (both P < 0.017); GFP(+) BMDCs were also observed in clusters within several SCC nests. Furthermore, most GFP(+) cells in SCC were pancytokeratin-positive (PCK(+)) epithelial cells, and some exhibited proliferative activity as determined by Ki67 staining (9.7 ± 3.92 %). The presence of GFP(+)Ki67(+)PCK(+) cells within SCC nests suggested that some donor BMDCs differentiated into proliferating epithelial cells. Finally, analysis of p63 expression, a marker of SCC cells, indicated that the presence of GFP(+)p63(+) cells (green) in inner parts of the SCC. These findings strongly suggest that BMDC-derived lung epithelial cells could participate in lung SCC formation and partially contribute to tumor growth, which might have significant potential implications for both clinical cancer therapy using BMDCs.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23055190     DOI: 10.1007/s13277-012-0522-0

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  27 in total

1.  Stem cells: Fusion brings down barriers.

Authors:  Alexander Medvinsky; Austin Smith
Journal:  Nature       Date:  2003-04-24       Impact factor: 49.962

2.  Single hematopoietic stem cells generate skeletal muscle through myeloid intermediates.

Authors:  Fernando D Camargo; Rahshaana Green; Yassemi Capetanaki; Kathyjo A Jackson; Margaret A Goodell; Yassemi Capetenaki
Journal:  Nat Med       Date:  2003-11-16       Impact factor: 53.440

3.  Hematopoietic myelomonocytic cells are the major source of hepatocyte fusion partners.

Authors:  Fernando D Camargo; Milton Finegold; Margaret A Goodell
Journal:  J Clin Invest       Date:  2004-05       Impact factor: 14.808

4.  Lack of a fusion requirement for development of bone marrow-derived epithelia.

Authors:  Robert G Harris; Erica L Herzog; Emanuela M Bruscia; Joanna E Grove; John S Van Arnam; Diane S Krause
Journal:  Science       Date:  2004-07-02       Impact factor: 47.728

Review 5.  Nicotine-derived N-nitrosamines and tobacco-related cancer: current status and future directions.

Authors:  D Hoffmann; S S Hecht
Journal:  Cancer Res       Date:  1985-03       Impact factor: 12.701

6.  Inhibition of N-nitrosodiethylamine- and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced tumorigenesis in A/J mice by green tea and black tea.

Authors:  Z Y Wang; J Y Hong; M T Huang; K R Reuhl; A H Conney; C S Yang
Journal:  Cancer Res       Date:  1992-04-01       Impact factor: 12.701

7.  Targeting of XIAP combined with systemic mesenchymal stem cell-mediated delivery of sTRAIL ligand inhibits metastatic growth of pancreatic carcinoma cells.

Authors:  Andrea Mohr; Stella Maris Albarenque; Laura Deedigan; Rui Yu; Mairead Reidy; Simone Fulda; Ralf Michael Zwacka
Journal:  Stem Cells       Date:  2010-11       Impact factor: 6.277

8.  Quantitative analysis of lentiviral transgene expression in mice over seven generations.

Authors:  Yong Wang; Yong-tao Song; Qin Liu; Cang'e Liu; Lu-lu Wang; Yu Liu; Xiao-yang Zhou; Jun Wu; Hong Wei
Journal:  Transgenic Res       Date:  2010-01-22       Impact factor: 2.788

9.  Bone marrow-derived cells are not the origin of the cancer stem cells in ultraviolet-induced skin cancer.

Authors:  Satomi Ando; Riichiro Abe; Mikako Sasaki; Junko Murata; Daisuke Inokuma; Hiroshi Shimizu
Journal:  Am J Pathol       Date:  2009-01-08       Impact factor: 4.307

10.  Donor-derived human bone marrow cells contribute to solid organ cancers developing after bone marrow transplantation.

Authors:  Itzhak Avital; Andre L Moreira; David S Klimstra; Margaret Leversha; Esperanza B Papadopoulos; Murray Brennan; Robert J Downey
Journal:  Stem Cells       Date:  2007-08-09       Impact factor: 6.277

View more
  3 in total

1.  Bone marrow-derived cells are recruited by the melanoma tumor with endothelial cells contributing to tumor vasculature.

Authors:  R Bonfim-Silva; L E B Souza; F U F Melo; V C Oliveira; D A R Magalhães; H F Oliveira; D T Covas; A M Fontes
Journal:  Clin Transl Oncol       Date:  2016-05-17       Impact factor: 3.405

2.  SDF-1/CXCR4 Axis Promotes MSCs to Repair Liver Injury Partially through Trans-Differentiation and Fusion with Hepatocytes.

Authors:  Ning-Bo Hao; Chang-Zhu Li; Mu-Han Lü; Bo Tang; Su-Min Wang; Yu-Yun Wu; Guang-Ping Liang; Shi-Ming Yang
Journal:  Stem Cells Int       Date:  2015-08-02       Impact factor: 5.443

3.  Lung Cancer Onset in Wild Type Mice Following Bone Marrow Reconstitution with kras(v12) Cells.

Authors:  Elena Belloni; Ines Martin Padura; Elvira Gerbino; Stefania Orecchioni; Fulvia Fusar Imperatore; Paola Marighetti; Giovanni Bertalot; Pier Giuseppe Pelicci; Francesco Bertolini
Journal:  Sci Rep       Date:  2015-08-12       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.